A majority of cancer drugs approved in the US during 2019-2022 had “clinical trial uncertainties,” research suggests.

55.8 percent of people with diabetes were diagnosed in 2023; 21.2 percent of those with diabetes had optimal glycemic concentrations.

NCD mortality declined in all high-income Western countries, with largest decline for both sexes in Denmark and smallest in U.S.

Anemia along with renal tubular damage (RTD) is associated with all-cause mortality in the general population, suggesting it’s a novel risk factor that could enhance prognostic ...

(HealthDay News) — Machine learning and deep learning models applied to integrated clinical and claims data can improve prediction of chronic kidney disease (CKD) progression to end-stage renal ...

(HealthDay News) — Consuming high levels of ultraprocessed foods is associated with increased levels of high-sensitivity C-reactive protein (hsCRP), according to a study published online Sept. 3 in ...